GlobalData: Reports by Subject
Catalog|Healthcare and Pharmaceuticals|Pharmaceuticals (9721 reports)
Additional Filter:

Sort by:

<< prev 1 2 3 4 5 6 7 8 9 10 next >>

1 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US
Published by GlobalData on May, 2013
$1995
2 EpiCast Report: Asthma - Epidemiology Forecast to 2022
Published by GlobalData on May, 2013
$3995
3 PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013
Published by GlobalData on May, 2013
$2995
4 Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. - Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
5 Acorda Therapeutics, Inc. (ACOR) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
6 Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
7 AMAG Pharmaceuticals, Inc. (AMAG) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
8 Amicus Therapeutics, Inc. (FOLD) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
9 AnGes MG, Inc. (4563) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
10 BioAlliance Pharma SA (BIO) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
11 Biodel Inc. (BIOD) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
12 BioElectronics Corporation (BIEL) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
13 BioLineRx, Ltd. (BLRX) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
14 Ceapro Inc. (CZO) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
15 Cellavision AB (CEVI) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
16 Cyprotex PLC (CRX) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
17 DARA BioSciences, Inc. (DARA) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
18 Immupharma Plc (IMM) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
19 Imprimis Pharmaceuticals, Inc. (IMMY) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
20 Intercell AG (ICLL) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
21 Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
22 Lightlake Therapeutics Inc. (LLTP) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
23 Mast Therapeutics, Inc. (MSTX) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
24 Millennium Pharmaceuticals, Inc. - Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125
25 MMRGlobal, Inc. (MMRF) - Financial and Strategic SWOT Analysis Review
Published by GlobalData on May, 2013
$125

<< prev 1 2 3 4 5 6 7 8 9 10 next >>